On 3 February 2015
GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the Company on 3 February 2015, to consider and take on record the Un-audited Financial Results for the quarter ended 31 December 2014 (Q3) with Limited Review done by the Statutory Auditors.Powered by Capital Market - Live News
